Unique ID issued by UMIN | UMIN000040283 |
---|---|
Receipt number | R000045958 |
Scientific Title | Prospective observational study evaluating amino acid dynamics during continuous renal replacement therapy |
Date of disclosure of the study information | 2020/05/07 |
Last modified on | 2022/02/25 15:49:34 |
Prospective observational study evaluating amino acid dynamics during continuous renal replacement therapy
Amino acid dynamics in patients receive continuous hemofiltration
Prospective observational study evaluating amino acid dynamics during continuous renal replacement therapy
Amino acid dynamics in patients receive continuous hemofiltration
Japan |
Patients who undergo continuous hemofiltration
Nephrology | Intensive care medicine |
Others
NO
To evaluate amino acid dynamics during continuous hemofiltration in patients who need continuous hemofiltration
Others
Survey
Exploratory
Pragmatic
Not applicable
Amino acid concentration in the blood
Amino acid loss in the filtrate
- Thirty-nine amino acid concentrations in the blood
- Thirty-nine amino acid concentrations in the filtrate
- Urine volume
Observational
18 | years-old | <= |
Not applicable |
Male and Female
(1) Patients with sepsis or acute kidney injury (KDIGO stage 1 or higher)
(2) Patients aged 18 years or older on the date of informed consent
(3) Patients who are able to provide written informed consent or whose legally acceptable representative is able to provide written informed consent
(1) Patients with liver failure
(2) Patients who need other blood purification therapy within 4 hours after the continuous hemofiltration is started
(3) Patients who need to change the conditions of continuous hemofiltration within 4 hours after the continuous hemofiltration is started
(4) Patients who need enteral nutrition or parenteral nutrition containing amino acids within 4 hours after the continuous hemofiltration is started
(5) Patients who are determined ineligible by the principal investigator
20
1st name | Hiroomi |
Middle name | |
Last name | Tatsumi |
Sapporo Medical University School of Medicine
Department of Intensive Care Medicine
060-0061
S1, W16-291 Chuo-ku, Sapporo
011-611-2111
tatsumi@qc4.so-net.ne.jp
1st name | Hiroomi |
Middle name | |
Last name | Tatsumi |
Sapporo Medical University School of Medicine
Department of Intensive Care Medicine
060-0061
S1, W16-291 Chuo-ku, Sapporo
011-611-2111
http://sapmedicu.com/residents_research.html
tatsumi@qc4.so-net.ne.jp
Department of Intensive Care Medicine, Sapporo Medical University School of Medicine
Otsuka Pharmaceutical Factory, Inc.
Profit organization
Japan
Otsuka Pharmaceutical Factory, Inc.
Institutional Review Board of Sapporo Medical University Hospital
S1, W16 Chuo-ku, Sapporo
011-611-2111
rskk@sapmed.ac.jp
NO
札幌医科大学附属病院
Sapporo Medical University Hospital
2020 | Year | 05 | Month | 07 | Day |
Unpublished
Completed
2020 | Year | 03 | Month | 03 | Day |
2020 | Year | 04 | Month | 09 | Day |
2020 | Year | 05 | Month | 11 | Day |
2021 | Year | 12 | Month | 31 | Day |
a prospective observational study
2020 | Year | 05 | Month | 01 | Day |
2022 | Year | 02 | Month | 25 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045958
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |